VCEL Stock Price, Vericel Corp Quote, Chart

Market Summary

USD46.11-0.31

Market Closed

-0.67%

VCEL Alerts

2 major insider sales recently.

VCEL Stock Price

View Fullscreen

VCEL RSI Chart

VCEL Valuation

Market Cap

2.2B

Price/Earnings (Trailing)

-699.77

Price/Sales (Trailing)

11.27

EV/EBITDA

139.69

Price/Free Cashflow

145.55

VCEL Price/Sales (Trailing)

VCEL Profitability

EBT Margin

5.17%

Return on Equity

-1.41%

Return on Assets

-0.9%

Free Cashflow Yield

0.69%

VCEL Fundamentals

VCEL Revenue

Revenue (TTM)

197.5M

Rev. Growth (Yr)

23.35%

Rev. Growth (Qtr)

42.59%

VCEL Earnings

Earnings (TTM)

-3.2M

Earnings Growth (Yr)

119.4%

Earnings Growth (Qtr)

455%

Breaking Down VCEL Revenue

Last 7 days

-2.3%

Last 30 days

-1%

Last 90 days

13.7%

Trailing 12 Months

53.8%

How does VCEL drawdown profile look like?

VCEL Financial Health

Current Ratio

4.49

Debt/Equity

0.06

Debt/Cashflow

2.68

VCEL Investor Care

Shares Dilution (1Y)

1.95%

Diluted EPS (TTM)

-0.08

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2023	169.3M	178.2M	185.2M	197.5M
2022	157.7M	155.2M	159.3M	164.4M
2021	132.1M	151.6M	153.8M	156.2M
2020	122.7M	116.6M	118.3M	124.2M
2019	94.6M	101.8M	109.8M	117.8M
2018	72.6M	74.6M	82.9M	90.9M
2017	56.5M	60.6M	63.9M	63.9M
2016	54.4M	53.7M	53.3M	61.2M
2015	39.6M	48.8M	50.5M	51.2M
2014	0	17.3M	23.0M	28.8M
2013	27.0K	30.0K	5.8M	11.5M
2012	11.0K	11.0K	2.0K	21.0K
2011	53.5K	41.7K	29.8K	18.0K
2010	0	89.0K	77.2K	65.3K
2009	0	182.0K	0	0

Get all data in R, Python etc through our Historical Stock Data APIs

Tracking the Latest Insider Buys and Sells of Vericel Corp

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Apr 18, 2024	colangelo dominick	sold	-780,325	44.59	-17,500	president and ceo
Apr 18, 2024	colangelo dominick	acquired	52,850	3.02	17,500	president and ceo
Apr 17, 2024	colangelo dominick	sold	-813,225	46.47	-17,500	president and ceo
Apr 17, 2024	colangelo dominick	acquired	52,850	3.02	17,500	president and ceo
Apr 09, 2024	rubino alan l	acquired	12,360	4.12	3,000	-
Mar 27, 2024	zerbe robert l md	sold	-169,046	51.57	-3,278	-
Mar 27, 2024	zerbe robert l md	acquired	12,259	3.74	3,278	-
Mar 14, 2024	colangelo dominick	acquired	52,850	3.02	17,500	president and ceo
Mar 14, 2024	colangelo dominick	sold	-770,350	44.02	-17,500	president and ceo
Mar 13, 2024	colangelo dominick	acquired	52,850	3.02	17,500	president and ceo

Which funds bought or sold VCEL recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
Apr 23, 2024	AMALGAMATED BANK	reduced	-28.06	38,000	777,000	0.01%
Apr 23, 2024	Louisiana State Employees Retirement System	reduced	-1.26	376,593	1,227,670	0.02%
Apr 23, 2024	FIFTH THIRD BANCORP	added	9.44	24,840	66,326	-%
Apr 23, 2024	KLR INVESTMENT ADVISORS, LLC	new	-	250,452	250,452	0.18%
Apr 23, 2024	REGIONS FINANCIAL CORP	new	-	221,502	221,502	-%
Apr 23, 2024	ARCADIA INVESTMENT MANAGEMENT CORP/MI	new	-	26,780	26,780	-%
Apr 22, 2024	RAYMOND JAMES & ASSOCIATES	reduced	-0.18	791,656	2,519,480	-%
Apr 22, 2024	PFG Investments, LLC	new	-	335,529	335,529	0.02%
Apr 22, 2024	MetLife Investment Management, LLC	unchanged	-	54,772	933,231	0.01%
Apr 19, 2024	NORDEN GROUP LLC	new	-	244,335	244,335	-%

Are Funds Buying or Selling VCEL?

Are funds buying VCEL calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own VCEL

No. of Funds

VCEL Alerts

2 major insider sales recently.

Unveiling Vericel Corp's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 14, 2024	brown capital management llc	14.29%	6,818,933	SC 13G/A
Feb 14, 2024	rtw investments, lp	6.7%	3,212,794	SC 13G/A
Feb 13, 2024	vanguard group inc	7.07%	3,374,093	SC 13G/A
Jan 25, 2024	state street corp	5.58%	2,664,883	SC 13G/A
Jan 22, 2024	blackrock inc.	16.6%	7,937,063	SC 13G/A
Jan 05, 2024	conestoga capital advisors, llc	5.23%	2,495,619	SC 13G/A
Feb 14, 2023	brown capital management llc	14.68%	6,931,641	SC 13G/A
Feb 14, 2023	rtw investments, lp	6.6%	3,099,904	SC 13G/A
Feb 09, 2023	state street corp	7.12%	3,364,203	SC 13G/A
Feb 09, 2023	vanguard group inc	7.00%	3,307,928	SC 13G/A

Recent SEC filings of Vericel Corp

View All Filings

Date Filed	Form Type	Document
Apr 19, 2024	4	Insider Trading
Apr 18, 2024	144	Notice of Insider Sale Intent
Apr 17, 2024	144	Notice of Insider Sale Intent
Apr 11, 2024	4	Insider Trading
Mar 29, 2024	4	Insider Trading
Mar 27, 2024	144	Notice of Insider Sale Intent
Mar 21, 2024	ARS	ARS
Mar 21, 2024	DEF 14A	DEF 14A
Mar 21, 2024	DEFA14A	DEFA14A
Mar 15, 2024	4	Insider Trading

Peers (Alternatives to Vericel Corp)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
MRNA	41.6B	6.8B	2.33%	-21.90%	-8.82	6.07	-64.45%	-156.37%
HILS	22.4B	152.6K	-0.77%	465779.94%	-2.4K	146.8K	-	-9.98%
ALNY	18.1B	1.8B	-0.30%	-28.67%	-41.14	9.91	76.23%	61.08%
BMRN	17.2B	2.4B	8.14%	-4.26%	102.64	7.11	15.42%	18.43%
INCY	11.6B	3.7B	-9.39%	-31.39%	19.44	3.14	8.87%	75.42%
MID-CAP
APLS	6.0B	396.6M	-12.04%	-45.12%	-11.39	15.18	425.83%	18.94%
BBIO	4.4B	-	-13.93%	67.39%	-6.74	60.35	54.84%	-34.79%
AXSM	3.4B	270.6M	-9.40%	-0.33%	-14.09	12.46	440.80%	-27.84%
ARWR	2.9B	240.7M	-12.61%	-20.79%	-9.72	12.18	-1.03%	-92.09%
ACAD	2.7B	726.4M	-6.74%	-16.88%	-44.6	3.76	40.45%	71.62%
SMALL-CAP
CPRX	1.8B	398.2M	-6.36%	-10.84%	24.96	4.48	85.90%	-14.05%
NVAX	580.8M	983.7M	-10.64%	-48.02%	-1.07	0.59	-50.36%	17.16%
CRBP	372.9M	881.7K	8.01%	271.09%	-8.36	466.16	-77.61%	-5.33%
INO	237.4M	4.9M	-10.76%	0.48%	-1.76	48.79	-54.97%	51.71%
IBIO	6.6M	2.1M	76.15%	62.71%	-0.24	2.14	-13.45%	66.37%

Vericel Corp News

Latest updates

Vericel Corp Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Income Statement (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Revenue	42.6%	64,996	45,581	45,922	41,017	52,694	38,551	37,046	36,074	47,591	34,506	39,519	34,568	45,229	32,258	20,014	26,678	39,390	30,499	26,151	21,810	31,335
Gross Profit	58.5%	48,507	30,608	29,941	26,520	38,249	25,233	22,854	23,452	34,032	22,098	26,910	22,985	33,647	22,471	11,354	16,756	28,805	21,175	17,129	13,170	22,706
Operating Expenses	0.3%	35,776	35,665	35,902	34,697	32,164	32,021	31,936	30,725	29,891	27,059	30,639	26,290	21,358	18,954	19,712	21,832	19,595	18,078	37,329	16,528	16,711
S&GA Expenses	3.0%	30,875	29,989	30,649	29,485	26,919	26,975	27,144	25,865	25,967	22,775	26,190	22,660	18,240	16,041	16,486	18,069	16,378	14,982	16,259	13,520	13,693
R&D Expenses	-13.7%	4,901	5,676	5,253	5,212	5,245	5,046	4,792	4,860	3,924	4,284	4,449	3,630	3,118	2,913	3,226	3,763	3,217	3,096	21,070	3,008	3,018
EBITDA Margin	288.8%	0.08*	-0.04*	-0.06*	-0.07*	-0.07*	-0.09*	-0.09*	-0.05*	-0.03*	0.02*	0.08*	0.06*	-	-	-	-	-	-	-	-	-
Interest Expenses	4.0%	156	150	149	145	223	105	20.00	18.00	1.00	1.00	1.00	1.00	1.00	2.00	1.00	2.00	2.00	2.00	2.00	2.00	-1,309
Income Taxes	484.6%	1,100	-286	-	-	700	21.00	-	-	-326	-	72.00	143	180	-	-	-	-	-	-	-	-
Earnings Before Taxes	457.1%	14,093	-3,946	-	-	6,622	-6,556	-8,963	-7,091	4,209	-4,931	-3,714	-3,146	12,400	3,618	-8,269	-4,705	-	-	-	-	-
EBT Margin	174.6%	0.05*	-0.07*	-0.09*	-0.09*	-0.10*	-0.12*	-0.11*	-0.07*	-0.05*	0.00*	0.06*	0.03*	-	-	-	-	-	-	-	-	-
Net Income	455.0%	12,993	-3,660	-5,020	-7,495	5,922	-6,577	-8,963	-7,091	4,535	-4,931	-3,786	-3,289	12,220	3,618	-8,269	-4,705	9,501	3,470	-19,792	-2,844	5,242
Net Income Margin	70.9%	-0.02*	-0.06*	-0.07*	-0.10*	-0.10*	-0.11*	-0.11*	-0.07*	-0.05*	0.00*	0.06*	0.03*	-	-	-	-	-	-	-	-	-
Free Cashflow	275.2%	2,251	600	6,000	6,447	5,850	2,692	1,162	387	9,560	1,171	2,651	7,743	-	-	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Assets	11.2%	354	318	311	265	273	248	245	240	244	224	222	211	206	158	147	150	153	138	126	141	119
Current Assets	10.4%	206	186	183	178	187	166	155	152	158	145	139	127	124	125	116	117	112	105	94.00	110	113
Cash Equivalents	14.2%	69.00	60.00	43.00	62.00	51.00	65.00	56.00	56.00	68.00	55.00	52.00	58.00	34.00	44.00	56.00	46.00	27.00	37.00	14.00	35.00	18.00
Inventory	3.7%	13.00	13.00	14.00	15.00	16.00	17.00	16.00	14.00	13.00	13.00	13.00	10.00	9.00	10.00	8.00	7.00	7.00	7.00	5.00	4.00	4.00
Net PPE	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	7.00	7.00	6.00	6.00
Liabilities	12.3%	128	114	112	71.00	81.00	70.00	70.00	68.00	73.00	67.00	71.00	71.00	71.00	43.00	39.00	40.00	42.00	41.00	37.00	38.00	16.00
Current Liabilities	27.3%	46.00	36.00	36.00	29.00	37.00	27.00	25.00	22.00	26.00	19.00	24.00	23.00	22.00	21.00	18.00	18.00	20.00	15.00	13.00	13.00	15.00
Shareholder's Equity	10.6%	226	204	199	194	192	178	175	172	170	157	151	140	134	115	108	110	111	97.00	89.00	103	102
Retained Earnings	3.1%	-403	-416	-412	-407	-399	-405	-399	-390	-383	-387	-382	-379	-375	-388	-391	-383	-378	-388	-391	-371	-369
Shares Outstanding	0.3%	48.00	48.00	48.00	48.00	47.00	47.00	47.00	47.00	46.00	47.00	46.00	46.00	-	-	-	-	-	-	-	-	-
Float	-	-	-	1,775	-	-	-	1,179	-	-	-	2,431	-	-	-	618	-	-	-	828	-	-

Cashflow (Last 12 Months)

(In Thousands)

Cashflow (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Cashflow From Operations	40.7%	10,086	7,169	10,196	7,860	6,975	4,101	3,143	3,468	10,551	3,634	4,769	10,086	11,337	4,570	-3,021	4,686	3,150	7,892	-18,379	154	2,611
Share Based Compensation	-12.8%	6,909	7,924	8,761	8,731	7,740	9,104	10,808	9,531	7,841	8,596	10,866	7,019	3,024	2,675	4,376	3,768	3,084	3,285	4,182	2,628	1,484
Cashflow From Investing	-277.1%	-8,088	4,566	-2,408	2,800	-21,729	-811	-2,997	-10,669	1,885	-2,629	-14,943	12,186	-25,678	-17,436	12,212	13,742	-14,604	13,368	-3,811	15,662	-20,446
Cashflow From Financing	29.5%	1,307	1,009	1,195	107	605	-312	249	503	1,341	1,787	3,781	2,262	4,454	791	890	306	1,527	1,683	1,068	982	-17,168

VCEL Income Statement

2023-12-31

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Income Statement [Abstract]
Revenue, Product and Service [Extensible List]	Product [Member]	Product [Member]	Product [Member]
Product sales, net	$ 197,516	$ 163,698	$ 153,075
Other revenue	0	667	3,109
Total revenue	$ 197,516	$ 164,365	$ 156,184
Cost, Product and Service [Extensible List]	Product [Member]	Product [Member]	Product [Member]
Cost of product sales	$ 61,940	$ 54,577	$ 50,159
Gross profit	135,576	109,788	106,025
Research and development	21,042	19,943	16,287
Selling, general and administrative	120,998	106,903	97,592
Total operating expenses	142,040	126,846	113,879
Loss from operations	(6,464)	(17,058)	(7,854)
Other income (expense):
Interest income	4,632	1,341	224
Interest expense	(600)	(366)	(4)
Other income	64	95	52
Total other income	4,096	1,070	272
Loss before income taxes	(2,368)	(15,988)	(7,582)
Income tax expense (benefit)	814	721	(111)
Net loss	$ (3,182)	$ (16,709)	$ (7,471)
Net loss per common share:
Basic (in USD per share)	$ (0.07)	$ (0.35)	$ (0.16)
Diluted (in USD per share)	$ (0.07)	$ (0.35)	$ (0.16)
Weighted-average common shares outstanding:
Basic (in shares)	47,590	47,130	46,472
Diluted (in shares)	47,590	47,130	46,472

VCEL Balance Sheet

2023-12-31

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 69,088	$ 51,067
Restricted cash	17,778	0
Short-term investments	40,469	68,471
Accounts receivable (net of allowance for doubtful accounts of $43 and $47, respectively)	58,356	46,539
Inventory	13,087	15,986
Other current assets	6,853	4,803
Total current assets	205,631	186,866
Property and equipment, net	41,635	15,837
Intangible assets, net	6,875	7,500
Right-of-use assets	73,462	41,535
Long-term investments	25,283	19,962
Other long-term assets	771	1,303
Total assets	353,657	273,003
Current liabilities:
Accounts payable	22,347	16,930
Accrued expenses	17,215	16,190
Current portion of operating lease liabilities	6,187	4,302
Other current liabilities	0	41
Total current liabilities	45,749	37,463
Operating lease liabilities	81,856	43,268
Other long-term liabilities	100	0
Total liabilities	127,705	80,731
COMMITMENTS AND CONTINGENCIES (Note 15)
Shareholders’ equity:
Common stock, no par value; shares authorized — 75,000; shares issued and outstanding — 47,829 and 47,253, respectively	629,229	593,245
Accumulated other comprehensive loss	(100)	(978)
Accumulated deficit	(403,177)	(399,995)
Total shareholders’ equity	225,952	192,272
Total liabilities and shareholders’ equity	$ 353,657	$ 273,003

About Vericel Corp

Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cultured chondrocytes on porcine collagen membrane for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; and Epicel, a permanent skin replacement humanitarian use device for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns. Its preapproval stage product is NexoBrid, a biological orphan product for eschar removal in adults with deep partial-thickness and/or full-thickness thermal burns. The company was formerly known as Aastrom Biosciences, Inc. Vericel Corporation was incorporated in 1989 and is headquartered in Cambridge, Massachusetts.

CEO	Mr. Dominick C. Colangelo Esq.
WEBSITE	https://vcel.com
INDUSTRY	Biotechnology
EMPLOYEES	305

Vericel Corp Frequently Asked Questions

What is the ticker symbol for Vericel Corp? What does VCEL stand for in stocks?

VCEL is the stock ticker symbol of Vericel Corp. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Vericel Corp (VCEL)?

As of Tue Apr 23 2024, market cap of Vericel Corp is 2.24 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of VCEL stock?

You can check VCEL's fair value in chart for subscribers.

What is the fair value of VCEL stock?

You can check VCEL's fair value in chart for subscribers. The fair value of Vericel Corp is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Vericel Corp is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for VCEL so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Vericel Corp a good stock to buy?

The fair value guage provides a quick view whether VCEL is over valued or under valued. Whether Vericel Corp is cheap or expensive depends on the assumptions which impact Vericel Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for VCEL.

What is Vericel Corp's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Tue Apr 23 2024, VCEL's PE ratio (Price to Earnings) is -704.47 and Price to Sales (PS) ratio is 11.35. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. VCEL PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Vericel Corp's stock?

In the past 10 years, Vericel Corp has provided 0.278 (multiply by 100 for percentage) rate of return.